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Abstract
Chlamydia pneumoniae is a common human and animal pathogen associated with a wide range of diseases. Since the first
isolation of C. pneumoniae TWAR in 1965, all human isolates have been essentially clonal, providing little evolutionary
insight. To address this gap, we investigated the genetic diversity of 30 isolates from diverse geographical locations, from
both human and animal origin (amphibian, reptilian, equine and marsupial). Based on the level of variation that we
observed at 23 discreet gene loci, it was clearly evident that the animal isolates were more diverse than the isolates of
human origin. Furthermore, we show that C. pneumoniae isolates could be grouped into five major genotypes, A-E, with A,
B, D and E genotypes linked by geographical location, whereas genotype C was found across multiple continents. Our
evidence strongly supports two separate animal-to-human cross species transfer events in the evolutionary history of this
pathogen. The C. pneumoniae human genotype identified in the USA, Canada, Taiwan, Iran, Japan, Korea and Australia (non-
Indigenous) most likely originated from a single amphibian or reptilian lineage, which appears to have been previously
geographically widespread. We identified a separate human lineage present in two Australian Indigenous isolates
(independent geographical locations). This lineage is distinct and is present in Australian amphibians as well as a range of
Australian marsupials.
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Introduction
Members of the family Chlamydiaceae are obligate intracellular
pathogens of a wide range of animals, birds and humans. Of the
nine currently recognised species (Chlamydia pneumoniae, Chlamydia
trachomatis, Chlamydia psittaci, Chlamydia suis, Chlamydia pecorum,
Chlamydia abortus, Chlamydia felis, Chlamydia muridarum and Chlamydia
caviae), C. pneumoniae has an extremely diverse host range (like C.
psittaci), being reported in humans [1], horses [2], reptiles [3],
amphibians [3–5] and several Australian marsupials, including
koalas [6] and bandicoots [7].
C. pneumoniae exposure is widespread in humans, with sero-
prevalence studies reporting 50% infection levels by age 20 and
reaching 80% in the elderly [8]. In humans, C. pneumoniae
infections can range from asymptomatic to severe respiratory
disease, including pneumonia. Less common presentations include
bronchitis, pharyngitis, laryngitis and sinusitis, making up 5% of
cases [9]. In addition to respiratory infections in humans, C.
pneumoniae has also been associated with atherosclerosis and stroke
[8,10], myocarditis [11], multiple sclerosis [12] and Alzheimer’s
disease [13].
Despite the widespread prevalence of C. pneumoniae in humans,
all isolates studied to date are extremely similar at the DNA level.
Four C. pneumoniae human isolates have had their full genome
sequenced: AR39 [14], CWL029 [15], J138 [16] and TW183
[17]. Genomic comparisons revealed a highly conserved (.99.9%)
gene order and organisation, with few deletions and less than 300
single nucleotide polymorphisms (SNPs) distinguishing the isolates.
This near clonality of C. pneumoniae human isolates that are
temporally and geographically separate, has been taken to indicate
that human infections are a relatively recent event [18] and that
the efficient respiratory spread of the agent explains how 60–80%
of adults worldwide have been infected at least once in their
lifetime [19].
In addition to infections in humans, C. pneumoniae infections
have been reported from a range of animals from an equally
diverse range of body sites, including respiratory (frog, snake,
bandicoot, koala, horse), liver and spleen (frog, iguana, chame-
leon), heart (turtle, snake, frog), conjunctival (koala) and urogenital
tract (koala) [3–5,7,20].
While there have been some previous genetic studies on the C.
pneumoniae animal isolates, these have generally been restricted to
partial sequencing of three genes, 16S ribosomal (r) RNA, ompA
(encoding the major outer membrane protein) and omcB (encoding
a large cysteine-rich protein) [4–6,21]. Recently, Rattei et al. [18]
examined the relationship of 38 C. pneumoniae isolates, from
PLoS Pathogens | www.plospathogens.org 1 May 2010 | Volume 6 | Issue 5 | e1000903measurement of genetic diversity within a representative set of 232
synonymous (s)SNPs (no amino acid change; reduced evolutionary
pressure). Although only two animal isolates (koala and frog) were
examined, two major points have emerged from this study (i) there
were 15 genotypes and four major clusters among the isolates, and
(ii) the animal lineages were basal to human lineages, suggesting
recent transmission to human through successive bottlenecks
150,000 years ago (based on an Escherichia coli molecular clock).
Myers et al. [22] recently sequenced the full genome of the C.
pneumoniae koala respiratory isolate, LPCoLN. C. pneumoniae koala
LPCoLN was largely homologous to the previously sequenced C.
pneumoniae human isolates, although it has several key differences.
There are 6,213 SNPs between the koala and human isolates, and
importantly, there are several examples of genes that are full-
length in the koala LPCoLN isolate, but which have become
truncated and fragmented in the human isolates [22]. These data
strongly suggest that the koala strain is ancestral to the sequenced
human isolates, and points to an animal-to-human cross host
transmission event in the (recent) past.
The full genome sequence of C. pneumoniae koala LPCoLN has
also enabled us to select additional target genes as the basis for an
extended genetic and phylogenetic comparison between a broad
range of C. pneumoniae animal (19) and human (11) isolates. The 30
C. pneumoniae isolates that we compared in the current study can be
grouped into three categories: (i) seven archival samples (frogs
BMTF- type 1 and BMTF-type 2, snakes Pufadd and Burpyth,
turtle GST, chameleon cham and iguana Iguana) for which
material was no longer available, and three isolates (human
LKK1, bandicoot WBB and frog CPXT1) with sequences
available in GenBank, restricting comparisons to the already
published gene sequences, usually partial 16S rRNA, ompA and
omcB, (ii) five C. pneumoniae isolates which have had their entire full
genome sequenced (koala LPCoLN and humans AR39, J138,
CWL029 and TW183), (iii) 15 isolates which were either available
as viable cultures (frog GBF, and humans WA97001 and IOL207)
or recoverable tissue material (frogs DE177 and 2040.3,
bandicoots B10, B26 and B37, koala EBB, potoroo Pot37, horse
N16, and humans SH-511, 1979, TOR1 and A03) which were
subjected to gene-specific PCR and sequencing.
Results/Discussion
Nucleotide diversity reveals distinct geographical
lineages
We had access to a total of 19 C. pneumoniae animal isolates
(seven marsupial, six amphibian, five reptilian and one equine) and
11 C. pneumoniae human isolates (Table S1). We targeted 23 genes
from these 30 isolates for analysis. However, due to technical
difficulties with some of the DNA preparations, we could not
obtain reliable sequence for all genes from all the isolates. C.
pneumoniae genotypes were assigned by sequence and phylogenetic
analyses of nucleotide sequences. Bootstrapped phylogenetic trees
are shown in Figure S1. Nucleotide and amino acid (aa)
alignments for each gene are presented in Figures S2, S3, S4,
S5, S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18,
S19, S20, S21, S22 and S23. We propose, on the basis of 21 sSNPs
from various genomic regions, that the C. pneumoniae isolates that
were sequenced successfully could be assigned to five common
genotypes, A-E (Table S2). The same genotypes were assigned to
isolates whose Genbank sequences were included in the analysis
(Table S2). The five genotypes show a distinct geographic
distribution among the isolates examined (Table S2). Genotype
A was common among Australian animals. Genotype B may be
indicative of African isolates. Genotype C has a worldwide
distribution and was the most common genotype identified.
Genotype D was unique to Australian Indigenous isolates.
Genotype E was the most variable C. pneumoniae genotype and
comprised the sole isolate from the United Kingdom. Below is a
gene-by-gene comparison to highlight the potential evolutionary
relationships among C. pneumoniae isolates.
Genes showing significant size variation/truncation/
deletion between isolates
The CPK_ORF00679 (LPCoLN locus designation: CPK) gene
encodes a Lamin 2-like protein, which is a conserved hypothetical
protein identified in C. pneumoniae and C. felis. This gene can be
used as a target gene for molecular differentiation of C. pneumoniae.
Sequence analysis of eight C. pneumoniae human (AR39, CWL029,
TW183, J138, TOR1, WA97001, SH-511 and 1979) and four C.
pneumoniae animal isolates (koala LPCoLN, bandicoot B26, frog
DE177 and horse N16) revealed a distinct size variation at the 59
end (Figure S2). Three animal isolates (bandicoot B26, koala
LPCoLN and frog DE177) had the full-length (833 bp) gene with
only five sSNPs among them. Primer walking was used to
determine the nucleotide sequence of horse N16 and the
Indigenous human isolates when initial attempts with the
degenerate primers failed to amplify a product, indicating more
distantly related sequences were present. Comparison of the eight
C. pneumoniae human isolates revealed the absence of 251 bp at the
59 end of six non-Indigenous human isolates, and only two non-
synonymous (n)SNPs (an amino acid change) across the gene.
Interestingly, both Australian Indigenous human isolates (SH-511
and 1979) have the 251 bp extended 59 region of the gene
(translating an 83 aa segment), which is identical to the extended
59 sequence of bandicoot B26, koala LPCoLN and frog DE177
isolates (Figure 1). A second variable region of the gene included a
15 bp indel (insertion/deletion), translating the sequence IADRF
position 244-248 aa. This five aa indel is present in isolates koala
LPCoLN, bandicoot B26, frog DE177, horse N16, and humans
SH-511 and 1979 (Figure 1).
The second length polymorphic gene, Membrane Attack
Complex/Perforin (MACPF), remains uncharacterised in Chla-
mydia species, however, its role in other pathogens suggests that it
may be virulence-related. Analysis of the partial-length sequence
(1,939 bp) revealed only one sSNP differentiating frog DE177
from koala LPCoLN and bandicoots B26 and B37 (Figure S3).
PCR confirmed the long version of the gene to be present in horse
N16 (data not shown), with 99% identity over the available
1,303 bp to frog DE177, koala LPCoLN and bandicoots B26 and
B37 (15 SNPs; data not shown). PCR and sequence analysis of
nine C. pneumoniae human isolates (AR39, AR39-2 ‘gene sequenced
Author Summary
Chlamydia pneumoniae is an intracellular bacterial patho-
gen with an extremely diverse host range (humans,
amphibians, reptiles and marsupials). We selected 23
target genes in order to investigate genetic diversity:
seven of these had been lost or gained by C. pneumoniae,
a further six were conserved, four were polymorphic
(defined by greater than 20 SNPs per 1 kbp; in this study),
and six were truncated or length polymorphic in one strain
or the other. Our research highlights that C. pneumoniae
animal isolates are much more genetically diverse than C.
pneumoniae human isolates, and have crossed the host
barrier to humans on at least two occasions. Our study
provides new insights into the evolution of this complex
pathogen.
Chlamydia pneumoniae Is Genetically Diverse
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SH511 and 1979) confirmed a length polymorphism (compared to
the animal isolates), as the result of a common 840 bp internal
deletion. Within this region there was a seven nucleotide indel
TGATCCT between positions 1,053–1,055 bp and 1,059–1,062,
found in 10 isolates (bandicoots B26 and B37, koala LPCoLN, frog
DE177, and humans AR39-2, IOL207, TOR1, WA97001,
SH511 and 1979). The indel sequence was absent from the four
published C. pneumoniae human genomes (AR39, CWL029, J138
and TW183) (Figure S3). A third polymorphism for this gene was
evident in Australian Indigenous human isolates SH511 and 1979,
which lacked an additional 270 bp fragment between positions
1,333–1,602 bp. The characterisation and identification of
polymorphisms within the MACPF should serve as a useful
Figure 1. Sequence comparison of CPK_ORF00679. Shown is a multiple sequence alignment of CPK_ORF00679 from bandicoot (B26), koala
(LPCoLN), frog (DE177), horse (N16) and human sequences (AR39, CWL029, J138, TW183, TOR1, WA97001, 1979 and SH511. There are two distinct indels:
(i) an extended segment at the 59 end of the amino acid coding sequence, and (ii) a five amino acid indel between positions 244–248. The alignment was
generated using Geneious version 4.7, where each amino acid is assigned its own colour. White shading indicates an amino acid variant.
doi:10.1371/journal.ppat.1000903.g001
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gene sequence can differentiate C. pneumoniae animal isolates from
Indigenous human and non-Indigenous human sources.
A significant difference between C. pneumoniae and other
chlamydial species is the absence of tryptophan biosynthesis
genes. Despite this absence, C. pneumoniae encodes a functional
aromatic amino acid (tryptophan) hydroxylase (AroAA-Hs) [23].
The C. pneumoniae aromatic amino acid hyrdoxylase has a unique,
extended 59 region among human isolates, which is absent from
koala LPCoLN [23]. To investigate whether the 59 region may be
host specific for C. pneumoniae human isolates, we examined the
sequence of a bandicoot isolate (B26) and four additional C.
pneumoniae human isolates (TOR1, WA97001, SH551 and 1979).
Sequence analysis confirmed the 244 bp extended 59 region in all
five isolates (identical sequence) (Figure S4). Therefore, the
extended 59 region does not appear to be human host-specific,
but may play an important role in regulating its function.
Polymorphic outermembrane protein (pmp) genes
The pmps are an important group of Chlamydia surface proteins
that have been considered as potential vaccine candidates. We
selected three variable pmps (unknown function) for analysis; (i)
pmpE/F2, (ii) pmpE/F3, and (iii) pmpG6. Partial-length sequence
comparisons (2,169 bp) of pmpE/F2 revealed four unique features
(Figure S5), including (i) a total of 64 scattered SNPs (23 nSNPs; 41
sSNPs) differentiating koala LPCoLN and bandicoot B26 from all
other isolates, (ii) 10 SNPs (8nSNPs; 2 sSNPs) for frog DE177, six
of which were shared with LPCoLN, and four of these were also
shared with human SH511 and human 1979 isolates, (iii) four
shared SNPs (3 nSNPs; 1 sSNP) between Australian Indigenous
human isolates SH511 and 1979, and (iv) one nSNP differentiating
human J138 from human isolates AR39, CWL029, J138, TW183,
TOR1, and WA97001.
A partial alignment (922 bp) of pmpE/F3, revealed four features
(Figure S6), including (i) a total of 20 SNPs (8 nSNPs; 12 sSNPs)
unique to koala LPCoLN, (ii) two shared SNPs (1 nSNP; 1 sSNP)
among koala LPCoLN and frog DE177, (iii) four nSNPs unique to
Australian Indigenous human isolates SH511 and 1979, and (iv)
no polymorphisms among non-Indigenous human isolates (AR39,
TW183, CWL029, J138, TOR1 and WA9001).
The role of pmpG6 is unknown, but owing to the variable
number of tandem repeats there may be a functional role in vivo.
Koala LPCoLN and two C. pneumoniae human isolates, TW183
and CWL029, have three tandem repeats of (i) 396 bp, (ii) 393 bp,
and (iii) 387 bp, whereas human isolates J138 and AR39 only have
two tandem repeats (missing ii – 393 bp). Primers were designed to
flank the variable repeat region where a 657 bp product was
indicative of 3 tandem repeats, and a 264 bp product was
indicative of only 2 tandem repeats (Figure 2). We examined eight
C. pneumoniae isolates by PCR, including koala LPCoLN and
human AR39 positive controls. Five isolates were confirmed to
have three tandem repeats (koala LPCoLN, bandicoot B26, frog
DE177, and humans SH511 and 1979) and three isolates were
identified with only two tandem repeats (humans AR39, WA9701
and TOR1) (Figure 2). This gene can be used as a marker for
intra-species variation, differentiating isolates by the size of their
PCR product.
Previously well-studied genes
The 16S rRNA and ompA genes have been extensively used to
distinguish and phylogenetically group chlamydial species [24–27].
Although not as informative as our newly identified target genes,
our analysis showed that 16S rRNA, ompA and omcB were evolving
in much the same way as our target genes. A portion of the 16S
rRNA gene sequence has been previously determined for several
C. pneumoniae animal isolates including koala LPCoLN, horse N16,
frogs DE177, CPXT1, GBF, BMTF-type 1 and BMTF-type 2,
snakes Pufadd and Burpyth, turtle GST, chameleon cham, iguana
Iguana, and human isolates AR39, CWL029, TW183, J138,
LKK1 and IOL207 [3–5,14–17,22,28–31]. We expanded this
comparison to include the additional animal isolates frog 2040.3,
bandicoots B10, B26 and B37, potoroo Pot37, koala EBB, and
human isolates TOR1, WA97001, SH511 and 1979 (Figure S7).
As expected from previous studies, the 16S rRNA sequences were
highly conserved between all animal and human isolates.
However, the minor differences (SNPs) might indicate some
interesting trends in C. pneumoniae evolution. Analysis of a 215 bp
segment revealed seven SNPs. Of these, two were unique to horse
N16 (position 88; G/A and 100; A/C). Frog DE177 had a 2 bp
insertion (position 84; T and 85; T), while frog BMTF-type 1 and
snake Puffadd shared one unique bp insertion (position 28; A). The
two remaining SNPs (position 21; A/G and 51; A/G) differenti-
ated bandicoot (B10, B26, B37 and WBB), koala (LPCoLN and
EBB), frog (GBF, 2040.3, DE177 and CPXT1), horse N16 and
Australian Indigenous human isolates (SH511 and 1979) from frog
(BMTF-type 1 and BMTF-type 2), iguana (Iguana), snake
(Puffadd) and non-Indigenous human isolates.
The C. pneumoniae ompA gene is much less variable, unlike other
species in which several variable domain regions flank diversity.
We examined the ompA variable domain 4 partial-length (258 bp)
sequence of 10 human and 16 animal C. pneumoniae isolates from
diverse geographical and anatomical locations. From the 258 bp
sequence, we identified a total of 27 SNPs (12 nSNPs; 15 sSNPs).
Horse N16 had the highest number of SNPs (relative to all other
isolates) with 19 unique SNPs (7 nSNPs; 12 sSNPs). All six
marsupial isolates (koalas LPCoLN and EBB, bandicoots B26, B37
and WBB, and potoroo Pot37) were identical in sequence, whereas
all 10 human isolates (AR39, CWL029, TW183, J138, TOR1,
Figure 2. Variable number of tandem repeats polymerase chain reaction (PCR) for the pmpG6 gene. Results from isolates with varying
tandem repeats are as follows: lane 1 koala LPCoLN/3 repeats; lane 2 bandicoot B26/3 repeats; lane 3 frog DE177/3 repeats; lane 4 human SH511/3
repeats; lane 5 human 1979/3 repeats; lane 6 human AR39/2 repeats; lane 7 human TOR1/2 repeats; lane 8 human WA97001/2 repeats; lane 9 no
template control, and; lane 10 MW, molecular weight maker X (Roche, Castle Hill, Australia).
doi:10.1371/journal.ppat.1000903.g002
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one another (Figure S8). Region 221–251 bp was the most
polymorphic, with a total of 16 SNPs, five of which differentiate
marsupial (B26, B37, WBB, EBB, LPCoLN and Pot37) and frog
(CPXT1, DE177 and GBF) isolates from frog (BMTF-type 1),
snake (Burpyth and puffadd), lizard (chameleon and iguana), turtle
(GST), horse (N16) and human isolates (AR39, CWL029, J138,
TW183, IOL207, LKK1, TOR1, WA97001, 1979 and SH511) at
nucleotide positions 225 (A/G), 227 (G/C), 231 (A/G), 236 (C/T)
and 244 (G/A/C).
The omcB gene encodes a large cysteine-rich protein, which
offers stabilisation through disulphide cross-linkage [32]. Five
SNPs were identified from the partial-length (386 bp) comparison
of 10 isolates (Figure S9). Three SNPs (2 nSNP; 1 sSNP) were
associated with koala LPCoLN, frog DE177 and frog GBF isolates.
One sSNP was shared between koala LPCoLN and frog GBF,
while another sSNP was unique to horse N16.
Two highly conserved genes from within the plasticity zone
include accC and pfk, encoding acetyl-CoA carboxylase, biotin
carboxylase and diphosphate-fructose-6-phosphate 1-phospho-
transferase, respectively. A partial length (302 bp) comparison of
accC revealed only four SNPs, two (position 31; C/A and 171; C/
T) differentiated seven non-Indigenous human isolates from two
Australian Indigenous human isolates and nine animal isolates. A
third SNP (position 185; G/A) was detected in horse N16 and two
human isolates (AR39 and J138). The fourth SNP (position 226;
T/C) was found in horse N16 and frog 2040.3 isolates (Figure
S10). A partial length (263 bp) comparison of pfk also revealed four
SNPs, two (1 nSNP; 1 sSNP) were unique to horse N16, while two
additional SNPs (C/T and G/A) were conserved in koala
LPCoLN, bandicoot B37 and frog GBF isolates (Figure S11).
Hypothetical genes or unique genes showing
characteristics specific to C. pneumoniae
The CP_1042 (AR39 locus designation: CP) gene encodes a
hypothetical protein, which is unique to the C. pneumoniae human
genome. The four fully-sequenced C. pneumoniae human isolates
(AR39, CWL029, J138 and TW183) have the full-length (558 bp)
gene, whereas koala LPCoLN is missing a 361 bp segment at the
59 end of the gene; the remaining nucleotides do not translate a
protein due to truncation mutations. In order to determine the
extent to which genetic diversity occurs in other animal isolates,
we examined a frog (DE177), bandicoot (B26), koala (EBB) and
horse (N16) isolate, as well as four additional human isolates
(TOR1, WA97001, SH511 and 1979) across the 558 bp gene
(Figure S12). Like koala LPCoLN, PCR (primers designed for the
full-length gene) was unable to detect a product for bandicoot B26
and koala EBB isolates. Interestingly, frog DE177 and horse N16
isolates have the full-length gene, indicating that CP_1042 is not
unique to C. pneumoniae human isolates. Horse N16 is highly
variable with a total of 56 unique SNPs, one of which is shared
with frog DE177 and Australian Indigenous human isolates,
SH511 and 1979 (Figure S12). All eight human isolates have the
full-length gene, with only two SNPs differentiating the non-
Indigenous and Australian Indigenous isolates. The fragmentation
in the marsupial isolates appears to be host-specific and may not
be essential for growth in the marsupial host.
The CP_0880 gene encodes a hypothetical protein, which is
variable among C. pneumoniae animal isolates, making it difficult to
obtain reliable sequence for frog DE177 and horse N16 isolates
despite many attempts at different primer set combinations. It was
possible to align a partial-length sequence (845 bp) for one
bandicoot (B26), two koala (LPCoLN and EBB) and eight human
isolates (AR39, CWL029, TW183, J138, TOR1, WA97001,
SH511 and 1979) (Figure S13). Of the eight human isolates, four
SNPs (2 nSNPs; 2 sSNPS) were detected in SH511 and 1979
Australian Indigenous isolates. Bandicoot B26 and koala LPCoLN
isolates were identical in sequence and had diverged from all other
isolates, the result of 110 unique SNPs. Of these SNPs, 74 led to an
amino acid change, while two SNPs (1nSNP; 1sSNP) were shared
with Australian Indigenous human SH511 and 1979 isolates.
The CP_0505 gene encodes a hypothetical protein. Sequence
analysis (Figure S14) of the partial-length (723 bp) gene revealed
four features (i) 13 SNPs (8 nSNPs; 5 sSNPs) unique to koala
LPCoLN and bandicoots B26 and B37, (ii) 42 SNPs (24 nSNPs; 18
sSNPs) unique to horse N16, (iii) two SNPs (1 nSNP; 1 sSNP)
unique to Australian Indigenous SH511 and 1979 isolates, while a
third sSNP was shared with bandicoots B26 and B37, koala
LPCoLN and horse N16 isolates, and (iv) a single bp deletion
distinguished frog DE177 from the non-Indigenous isolates
(identical sequence).
The SctC gene encodes a type III secretion system protein,
which has a C. pneumoniae-specific (approximately 700 bp) 59
region. Type III secretion system proteins are well-conserved
among Chlamydia species (and other bacteria), therefore, it was not
surprising to find little variation among the C. pneumoniae isolates.
Overall, there were five SNPs. Two nSNPs (position 232; A/C and
273; A/C) distinguished bandicoot B26, koala LPCoLN, frog
DE177 and Indigenous human isolates SH511 and 1979 from the
non-Indigenous human isolates AR39, CWL029, J138, TW183,
TOR1 and WA97001 (identical sequences). Frog DE177 had one
sSNP (position 342; T/C). Koala LPCoLN and bandicoot B26
had the same nSNP (position 429; G/T). Australian Indigenous
human isolates SH511 1979 shared one nSNP (position 469; A/G)
(Figure S15). This 482 bp gene segment might be a useful marker
for C. pneumoniae detection and differentiation of animal isolates
from Indigenous and non-Indigenous human isolates, on the basis
of five key SNPs.
The CPK_ORF00201 gene (termed HAF) encodes a HAF
family auto-transporter beta domain protein. Nucleotide compar-
isons of the fully-sequenced C. pneumoniae isolates (koala LPCoLN
and human AR39, CWL029, TW183 and J138) revealed a
truncated (two separate genes) homolog among human isolates;
absence of a 120 bp internal segment. A partial-length (1,412 bp)
comparison with seven previously un-sequenced C. pneumoniae
isolates (bandicoot B26, frog DE177, horse N16, human
WA97001, TOR1, SH511 and 1979) revealed an intact, full-
length gene in all seven isolates (Figure S16). One possible
explanation for this difference may be due to sequencing error in
the C. pneumoniae human genomes; the missing segment is revealed
in a BLAST search. Limited sequence was available for horse N16,
despite many attempts with different primer sets, suggesting that
there may be more sequence variation in the region that could not
be amplified. There were, however, nine unique SNPs (4 nSNPs; 5
sSNPs) detected in the horse N16 isolate. It is worth mentioning
that horse N16, bandicoot B26, koala LPCoLN, frog DE177 and
both Australian Indigenous human isolates (SH511 and 1979) had
two common SNPs at nucleotide positions 761/T and 1,020/T,
while six non-Indigenous human isolates had C/C at these
positions. These polymorphisms could be used to distinguish
animal and Indigenous human isolates from non-Indigenous
human isolates.
Strain-specific genes of C. pneumoniae
Three genes present in the C. pneumoniae human genome, but
absent from the koala LPCoLN genome include guaA (GMP
synthase), guaB (IMP dehydrogenase) and add (AMP adenosine
deaminase). This three-gene cluster, located in the plasticity zone,
Chlamydia pneumoniae Is Genetically Diverse
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isolates. A comparison of guaB (Figure S17) revealed just three
SNPs differentiating frog DE177 from the non-Indigenous human
C. pneumoniae isolates (AR39, CWL029, TW183, J138, TOR1 and
WA97001), while no polymorphisms were evident in the guaA gene
(Figure S18). Reliable add sequence was not available for frog
DE177 (Figure S19). The horse N16 isolate had four unique SNPs
for guaB (Figure S17); however, reliable sequence was not available
for guaA and the presence of add was not definitive in the horse
N16 isolate. The guaBA-add cluster was identified (identical
sequence) in human isolates TOR1, WA97001 and IOL207
(limited sequence) (Figures S17, S18 and S19). Both Australian
Indigenous human isolates (SH511 and 1979) have the guaB gene
with six SNPs (4 nSNPs; 2 sSNPs) to the non-Indigenous human
isolates; two SNPs were shared with frog DE177 and horse N16
isolates (Figure S17). Since PCR failed to amplify any product for
guaA and add genes in the Australian Indigenous human isolates
(using two sets of primers for each gene from either 59 or 39
regions), these two genes are either absent from the genome, or are
highly divergent and undetectable with our primer sets. Three
additional animal isolates (koala EBB, bandicoots B26 and B37)
also lack the guaBA-add cluster which suggests that it is not a core
component required for C. pneumoniae survival.
The CPK_ORF00678 gene encodes a hypothetical protein,
which is located within the plasticity zone of the koala LPCoLN
genome. This gene was not identified in any of the four fully-
sequenced C. pneumoniae human isolates (AR39, CWL029, J138
and TW183) or subsequent human isolates (WA97001, TOR1,
SH511 and 1979), but was detected in three additional animal
isolates (bandicoot B26, frog DE177 and horse N16) (Figure S20).
A partial-length sequence comparison (698 bp) revealed 10 SNPs
(4 nSNPs; 6 sSNPs) differentiating frog DE177 from koala
LPCoLN and bandicoot B26 isolates (identical sequence). Four
of these SNPs were also shared with horse N16 (Figure S20). Of
the animal isolates, horse N16 showed greater sequence
divergence with 11 unique SNPs and four indels (positions 73–
84, 151–305, 387–395 and 419–425). The absence of
CPK_ORF00678 from the C. pneumoniae human genome suggests
that this gene may have been selected for a specific function in the
animal host, and thus, provides a new animal C. pneumoniae-specific
target gene.
Koala LPCoLN encodes a plasmid (7,655 bp) with eight ORFs
(open reading frames) [22]. This plasmid is absent from C.
pneumoniae human isolates [14–17]. Thomas et al.[ 3 3 ]d e t e c t e da
plasmid in the horse N16 isolate, and so it was of interest to see
whether additional C. pneumoniae isolates have a plasmid. Primers
(Table S3) were designed to investigate three plasmid ORFs: (i)
site-specific recombinase II; SSR2, (ii) replicative DNA helicase
dnaB; helicase, and (iii) a conserved hypothetical protein;
PGP3D. Seventeen isolates were examined by PCR for the
presence of a plasmid, including three bandicoots (B10, B26 and
B37), three frogs (GBF, DE177 and 2040.3), two koalas (LPCoLN
and EBB), one potoroo (Pot37), one horse (N16) and seven
human isolates (AR39, IOL207, WA97001, A03, TOR1, SH511
and 1979). All three plasmid ORFs were confirmed by PCR in
each of the 10 animal isolates, although no human isolate was
found to have SSR2 (Figure S21), helicase (Figure S22) or
PGP3D (Figure S23) ORFs. Of the three ORFs, SSR2 showed
evidence of a length difference when compared to the horse
N16 isolate. This isolate was missing a 165 bp segment between
positions 66–230 bp, while bandicoots B10 and B37, frogs
DE177, 2040.3, GBF and koala LPCoLN sequences were
identical and contained the whole 369 bp segment under
examination (Figure S21).
Phylogenetic relationships among C. pneumoniae isolates
Despite the importance and widespread prevalence of C.
pneumoniae, there has been little phylogenetic analysis to assist
evolutionary and epidemiological investigations. Therefore, in
order to examine in-depth the evolutionary relationships within C.
pneumoniae, we examined several previously studied isolates in
addition to 10 novel isolates using 22 target genes selected from
various regions of the genome. We constructed rooted phyloge-
netic trees from all available C. pneumoniae isolates by Neighbour-
Joining and UPGMA (Unweighted Pair Group Method with
Arithmetic mean) methods. As both trees were of similar structure,
only the Neighbour-Joining tree is presented (Figure S1). The
phylogenetic patterns that we observed were congruent in 19 out
of the 22 genes that we analysed. This gives us confidence that our
interpretations are sound and suggests that horizontal gene
transfer is not a major contributor to genetic changes in C.
pneumoniae. These phylogenetic analyses led us to propose several
key new findings. The Australian Indigenous human isolates
(genotype D) formed a unique group in 10 out of the 15 trees
analysed. These could be clearly distinguished from the non-
Indigenous human isolates (genotype C) which formed a tight
cluster, regardless of their geographical origin. The evolutionary
position of horse N16 (genotype E) is somewhat less confident.
Horse N16 was distinct from all other isolates in at least 9 out of
the 13 trees examined. However, the bootstrap values were low at
54–78%. It will be necessary to obtain additional equine isolates to
confirm the correct lineage of this strain. The Australian marsupial
isolates formed a tight grouping (genotype A) with all genes
analysed, even when they were obtained from different geograph-
ical regions within Australia. The Australian marsupial isolates
shared common nucleotide substitutions with the amphibian and
horse isolates originating from Australia, Africa and the United
Kingdom, as did the Australian Indigenous human isolates.
Analysis of the Australian frog isolates resulted in the identification
of two distinct genotypes. Genotype C was identified in two
captive frog isolates from New South Wales (BMTF-type 1 and
BMTF- type 2). A third free-range frog (GBF) isolate, also from
New South Wales, was identical to the sequence derived from
Australian marsupial isolates, from independent regions. The third
isolate was therefore clustered into genotype A. The degree of
variation in the limited sequence analysed was unusual given the
geographical distance from other world regions. Moreover, two
African frog isolates from different regions were clustered together,
in genotype B. However, a third African isolate from a chameleon
was grouped with the international cluster in genotype C,
comprising American snakes, an American turtle, a Central
American iguana, Australian frogs, as well as the non-Indigenous
human isolates. Members of genotype C are both common and
present across the globe, possibly indicating that it is a relatively
recent expansion, as proposed by Rattei et al. [18].
Conclusions
Sequence data suggests that two separate animal to
human transmission events have occurred. Our aim was
to determine whether our target genes could distinguish C.
pneumoniae isolates from human and animal sources and to
investigate their genetic diversity. Previous analyses have shown
that C. pneumoniae human isolates are essentially clonal and do not
provide much evolutionary insight. To our knowledge, all previous
analyses of C. pneumoniae human have focussed on non-Indigenous
isolates: AR39 (USA), CWL029 (USA), TW183 (Taiwan), J138
(Japan), LKK1 (Korea), A03 (USA), TOR1 (Canada) and IOL207
(Iran). Our analysis also included a non-Indigenous human isolate
from Australia (WA97001), and more importantly, we were able to
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1979) which originated from geographically separate communities.
Our collective sequence data (using 23 target genes from 30
isolates) and phylogenetic analyses strongly support both the whole
genome findings of Myers et al. [22] as well as the synonymous
SNP conclusions of Rattei et al. [18] in that the extant C. pneumoniae
human isolates have derived from C. pneumoniae animal isolates.
Our data extends both of these studies, however, and strongly
suggests two (or more) lineages of C. pneumoniae. One lineage
involves amphibian isolates (DE177, CPXT1, BMTF-type 1 and
BMTF-type 2), which subsequently ‘evolved’ to C. pneumoniae
infections in reptiles (Iguana, Pufadd, Burpyth, GST, cham) and
via as yet undiscovered intermediates, to the dominant C.
pneumoniae human clone present in the world today (AR39,
TW183, CWL029, J138, TOR1, A03, IOL207, LKK1, and
WA97001). The second presumably also started with amphibian
infections (as above), but then diverged into other amphibian and
reptilian infections (frogs GBF and 2040.3). At this point (there are
probably intermediate hosts and C. pneumoniae strains that are
either extinct or as yet, undiscovered) two sub-lines are evident.
One lineage has resulted in the widespread C. pneumoniae infections
seen in Australian marsupials today (koala LPCoLN, koala EBB,
bandicoot B10, bandicoot B26, bandicoot B37, bandicoot WBB
and potoroo Pot37) while the second lineage has crossed the
animal-human barrier to infect Australian Aboriginals (SH511
and 1979). The key genomic data, which supports these lineages
and their divergence is summarised in Supporting Information
Text S1.
Although the evolutionary time-frame of C. pneumoniae is
unclear, we have described patterns of genetic differentiation
whereby C. pneumoniae profiles from the Australian Indigenous
human populations appear to be negatively correlated (for the
most part) with the genetic differentiation in non-Indigenous
human populations. The possibility that C. pneumoniae was an
established pathogen in Australia before the settlement of
Europeans in 1788, is one possible theory considering the
characteristic diseases of a hunter-gatherer population have been
described as those with low morbidity, long illness and long
infection stages, such as chlamydial diseases [34]. From ancient
times, hunter-gatherer Aboriginal communities have lived in close
proximity to animals, and may have been predisposed to C.
pneumoniae infected animals. However, if C. pneumoniae had been
present in the Australian Indigenous population prior to European
settlement, the differences observed in our target genes would
suggest that the Australian Indigenous isolates have evolved
independently from the non-Indigenous isolates. This trend was
also observed in an Australian Indigenous and non-Indigenous
cohort of Haemophillus influenzae isolates from Australia [35] where
the genetic diversity and the time span from European settlement
was not likely to support the amount of differentiation observed. A
likely explanation for the observed diversity in our human isolates
would be that C. pneumoniae may have been more recently
introduced to urban non-Aboriginals from infected animals, or
alternatively via native or non-native inhabitants in other regions
around the world, and the infections were not derived from the
Indigenous Australians; the United Kingdom horse (N16) and
African frog (DE177) isolates also had indels in common to the
Australian marsupials (koalas LPCoLN and EBB, bandicoots B10,
B26, B37 and WBB, and potoroo Pot37) and Australian
Indigenous human isolates, despite being geographically isolated
from the Australian population. There is convincing evidence that
zoonotic transmission of C. pneumoniae can/has occur/ed. The
finding that a genotype common to non-human and human hosts
was dispersed in human carotid plaques [36] is not by itself
conclusive evidence of zoonotic transmission, but rather highlights
the need for consideration of its zoonotic potential, particularly for
animal handlers and laboratory personnel.
In the present study, we observed five genotypes (A-E) based on
genetic and phylogenetic data. These data revealed dominant
genotypes in various regions of the world. Genotype A was
prevalent among Australian animals, genotype B was identified in
Africa, genotype C had the broadest distribution and was
worldwide, genotype D was predominant among Indigenous
Australians, while genotype E was unique to the United Kingdom.
Although a very limited number of isolates were used in this study,
the results clearly showed genetic diversity associated with host
type and geographic locations. Based on the large number of
polymorphisms between horse N16 and all other C. pneumoniae
isolates, we believe that we have identified sufficient genetic
differences that would accommodate the classification of horse
N16 into a subspecies of C. pneumoniae, designated C. pneumoniae
subsp. equi, following the proposal of Pettersson et al. [29]. These
findings of high genetic variation may represent mosaic genotypes
in the population and may need to be considered as a subspecies
variant within C. pneumoniae.
Materials and Methods
Chlamydia pneumoniae isolates
30 isolates from 11 human, 7 marsupial, 5 reptilian, 6
amphibian and 1 equine host were analysed (Table S1).
The C. pneumoniae Pot37 isolate was initially obtained from a
pharyngeal swab of a Gilbert’s potoroo (Potorous gilbertii) from
Perth, Western Australia in 2006. The C. pneumoniae EBB isolate
was isolated from a pharyngeal swab of a koala (Phascolarctos
cinereus) from Queensland, Australia in 2005.
All analyses involving the Australian Indigenous human samples
were approved by the Queensland University of Technology and
the Menzies School of Health Research, Human Research Ethics
Committee. All human samples were obtained from a previous
study, in which informed written consent for the collection of
samples and subsequent analysis was correctly obtained and ethics
approval obtained. All animal samples were obtained from
previous studies and experiments were performed according to
national and institutional guidelines with ethics, biosafety and
animal care committee approval (QUT IBC No. 1413/2A, QUT
IBC No. 0900000267, QUT IBC No. 928A).
Strategy for selection of genes used for comparisons
Recently, we examined five complete C. pneumoniae genomes,
including koala LPCoLN and the four available C. pneumoniae
human (AR39, TW183, CWL029 and J138) genomes (Mitchell et
al., unpublished data). This approach allowed us to identify regions
of high SNP accumulation and to select candidate genes for
comparison. In this study, we selected 13 of these genes for
comparative analysis using a broader selection of isolates, while 1
additional length variable gene, 1 polymorphic gene, 5 highly
conserved genes and three plasmid genes were also selected for
analysis. Our target genes could be grouped into six categories:
(i) three genes (CPK_ORF00679, AroAA-Hs and MACPF)
showing length polymorphisms, of at least 100 bp between
C. pneumoniae koala and human isolates. Aromatic amino
acid hydroxylases (AroAA-Hs) hydroxylate phenylalanine,
tyrosine, and tryptophan into tyrosine, dihydroxyphenyl-
alanine, and 5-hydroxytryptophan, respectively [23].
CPK_ORF00679 and MAC/perforin (MACPF) genes
have an unknown role, although the MACPF may be a
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intracellular pathogens.
(ii) three polymorphic outer membrane protein genes; two
(pmpE/F2 and pmpE/F3) have regions with more than 20
SNPs per 1 kbp between C. pneumoniae koala and human
isolates, and one (pmpG6) varies in the number of tandem
repeats.
(iii) three previously well-studied ‘conserved’ genes: 16S rRNA
belongs to a small unit of ribosomes, ompA is a major
outermembrane protein and omcB is a large cysteine-rich
outer membrane protein; and two highly conserved genes
(accC and pfk) located within the plasticity zone – accC
(acetyl-CoA carboxylase, biotin carboxylase) is involved in
fatty acid/phospholipid metabolism and pfk (diphosphate-
fructose-6-phosphate 1-phosphotransferase) is involved in
glycolysis/gluconeogenesis.
(iv) three hypothetical genes (CP_1042, CP_0880 and
CP_0505) with an unknown function.
(v) two C. pneumoniae-specific genes (SctC and HAF). SctC
(highly conserved) forms part of the type III secretion
system and has a unique 700 bp at the 59 region of the
gene. HAF is predicted to be a HAF family-autotranspor-
ter (beta domain) protein.
(vi) seven strain-specific genes: guaA (GMP synthase), guaB
(IMP dehydrogenase) and add (AMP adenosine deaminase)
are located in the plasticity zone and were absent from
koala LPCoLN; CPK_ORF00678 is a hypothetical gene
that is absent from all four full-sequenced C. pneumoniae
human isolates, and; the plasmid is an extra-chromosomal
element identified in the koala LPCoLN genome. Three
plasmid genes were examined: (i) site-specific recombinase
II; SSR2, (ii) replicative DNA helicase dnaB; helicase, and
(iii) a conserved hypothetical protein; PGP3D.
The strategy involved PCR-based amplification of six human
isolates and nine animal isolates, followed by sequencing of the
PCR products. Additional sequences for 16S rRNA, ompA and
omcB were retrieved for previously sequenced human and animal
C. pneumoniae isolates (refer to accession numbers). The analysis
included; (i) gene by gene sequence alignments to identify SNPs
and indels, and (ii) generation of bootstrapped phylogenetic trees.
PCR and sequencing
Oligonucleotide primers (Sigma-Aldrich, Castle Hill, Australia)
were designed based on homology of C. pneumoniae LPCoLN and
AR39 sequences (GenBank accession numbers CP001713 and
AE002161) using Primer3 v. 0.4.0 (denoted by an asterisk) (http://
biotools.umassmed.edu/bioapps/primer3_www.cgi) [37] and two
primers already published (Table S3). The primer pairs, expected
PCR product sizes and annealing temperatures are summarised,
and several of the target genes have internal primers to sequence a
particular region because of sequence variation or to enable
sequencing of whole PCR products (Table S3). PCR reactions
were performed in a final volume of 50 ml, including 5.0 ml 10X
PCR reaction buffer (Roche, Castle Hill, Australia), 1.0 ml PCR
nucleotide mix (Roche, Castle Hill, Australia), 2.0 ml of each
(10 mM) primer (Sigma-Aldrich, Castle Hill, Australia), 0.2 mlo f
5U / ml Taq DNA polymerase (Roche, Castle Hill, Australia),
2.0 ml of template and PCR grade water to a final volume of 50 ml.
Amplification conditions consisted of an initial denaturation at
94uC, followed by 30 cycles of 1 min at 94uC, 1 min at the
specified annealing temperature (refer to Table S3), 1 min at 72uC,
and a final extension for 10 min at 72uC. PCR products were
separated by electrophoresis and visualised by ethidium bromide
(10 mg/ml) staining of a 2% agarose gel in Tris Borate EDTA
(TBE) buffer.
PCR products were purified with a PureLink PCR purification
kit (Invitrogen, Australia). To confirm sequence confirmation,
DNA sequencing was performed in both directions using a BigDye
terminator Cycle Sequencing Ready Reaction Kit and an
automated DNA sequencer AB 3730xl (Australian Genome
Research Facility, University of Queensland, Australia). A third
sequence was obtained if required.
Sequences and phylogeny
Nucleotide sequences were translated to amino acids using
blastx (www.ncbi.nlm.nih.gov/blast). Nucleotide and derived
amino acid sequences were then trimmed to a uniform length.
Sequence alignments were generated with Geneious version 4.7
using the pairwise alignment default settings (Nucleotide Cost
Matrix=65% similarity 5.0/24.0, Protein Cost Matrix=Blo-
sum62, Gap Open=12.0, Gap Extension=3.0, Alignment Type
= global alignment with free end gaps) [38; http://www.geneious.
com]. The amino acid colour scheme is standard where each
amino acid has an assigned colour. Phylogenetic trees were
generated with Geneious version 4.7 using the pairwise alignment
default settings (described above), and a bootstrap consensus
phylogenetic tree was constructed by Neighbor-Joining or
UPGMA analysis and Jukes-Cantor correction using 1,000
bootstrap replicates [38]. Bootstrap values greater than or equal
to 50% are shown at the nodes.
Nucleotide and amino acid sequence accession numbers
The nucleotide and amino acid sequence of the target genes
have been deposited in the GenBank database, and the accession
numbers are as follows: CPK_ORF00679 GQ918195 to
GQ918201; MACPF GQ918233 to GQ918240; AroAA-Hs
GQ918166 to GQ918170; pmpE/F2 GQ507462 to GQ507467;
pmpE/F3 GQ918162 to GQ918165; 16S rRNA GQ507433 to
GQ507442; ompA GQ918216 to GQ918222; accC GQ918224 to
GQ918232, GU013548; pfk GQ918243 to GQ918254; CP_1042
GQ918189 to GQ918194; CP_0880 GQ507456 to 507461;
CP_0505 GQ507449 to GQ507455; SctC GQ507443 to
GQ507448; HAF GQ918202 to GQ918208; guaA GQ918156 to
GQ918158; guaB GQ918209 to GQ918215; add GQ918154 to
GQ918155; CPK_ORF00678 GQ918159 to GQ918161; SSR2
GQ918171 to GQ918176; helicase GQ918183 to GQ918188;
PGP3D GQ918177 to GQ918182.
Supporting Information
Figure S1 Phylogenetic trees (A-V) of C. pneumoniae
isolates. Phylogenetic relationships of C. pneumoniae isolates were
inferred from partial nucleotide sequences, and were constructed
by Neighbor-Joining analysis and the Jukes-Cantor correction
model using 1,000 bootstrap replicates. (A) CPK_ORF00679, (B)
MACPF, (C) AroAA-Hs, (D) pmpE/F2, (E) pmpE/F3, (F) 16S
rRNA, (G) ompA, (H) omcB, (I) accC, (J) pfk, (K) CP_1042, (L)
CP_0880, (M) CP_0505, (N) ScTc, (O) HAF, (P) guaB, (Q) guaA,
(R) add, (S) CPK_ORF00678, (T) SSR2, (U) helicase, and (V)
PGP3D. There is evidence of five distinct phylogenetic groupings
among isolates. These groupings correspond to the five proposed
genotypes, A-E (Table S2). The 19/22 trees were congruent, while
the phylogenetic incongruities that were observed in 3 trees (H, J
and M) may be the result of host interactions or adaptation, rather
than acquisition through horizontal transfer. The nomenclature
for each isolate is shown in Table S1.
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Figure S2 Multiple sequence alignment of CPK_
ORF00679. Note the size variation at the 59 end and the indel
at nucleotide positions 732-746.
Found at: doi:10.1371/journal.ppat.1000903.s002 (3.29 MB PDF)
Figure S3 Multiple sequence alignment of MACPF.
Animal isolates have the full-length gene, whereas human isolates
have an 840 bp/280 aa internal deletion. There is a seven
nucleotide indel (TGATCCT) present between 1,053-1,055 bp
and 1,059-1,062 bp. An additional polymorphism (270 bp
deletion) was present in two Australian Indigenous isolates
SH511 and 1979 between positions 1,333-1,602.
Found at: doi:10.1371/journal.ppat.1000903.s003 (4.11 MB PDF)
Figure S4 Multiple sequence alignment of AroAA-Hs.
Sequence from bandicoot (B26), koala (LPCoLN) and six human
isolates (AR39, TW183, CWL029, J138, SH511 and 1979)
identified a 244 bp length polymorphism at the 59 end.
Found at: doi:10.1371/journal.ppat.1000903.s004 (6.05 MB PDF)
Figure S5 Multiple sequence alignment of pmpE/F2.
The nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s005 (6.27 MB PDF)
Figure S6 Multiple sequence alignment of pmpE/F3.
The nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s006 (1.72 MB PDF)
Figure S7 Multiple sequence alignment of 16S rRNA.
The nucleotide alignment was generated using Geneious version
4.7, where each nucleotide is assigned its own colour. The total
alignment length is 215 bp.
Found at: doi:10.1371/journal.ppat.1000903.s007 (4.92 MB PDF)
Figure S8 Multiple sequence alignment of ompA. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s008 (1.42 MB PDF)
Figure S9 Multiple sequence alignment of omcB. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s009 (0.94 MB PDF)
Figure S10 Multiple sequence alignment of accC. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s010 (0.71 MB PDF)
Figure S11 Multiple sequence alignment of pfk. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s011 (0.96 MB PDF)
Figure S12 Multiple sequence alignment of CP_1042.
Sequence from koala (LPCoLN), frog (DE177), horse (N16), and
six human isolates (AR39, CWL029, J138, TW183, SH511
and 1979) revealed gene fragmentation in the koala LPCoLN
isolate.
Found at: doi:10.1371/journal.ppat.1000903.s012 (1.13 MB PDF)
Figure S13 Multiple sequence alignment of CP_0880.
The two koala isolates (LPCoLN and EBB) and bandicoot isolate
(B26) are identical in sequence and have diverged genetically (110
SNPs) from the eight human isolates (AR39, CWL029, J138,
TW183, TOR1, WA97001, SH511 and 1979). There are two
shared polymorphisms (positions 714 and 818 bp) among koala
LPCoLN, bandicoot B26 and Indigenous human isolates SH511
and 1979.
Found at: doi:10.1371/journal.ppat.1000903.s013 (5.80 MB PDF)
Figure S14 Multiple sequence alignment of CP_0505.
There are four features of interest: (i) 13 SNPs unique to koala
LPCoLN and bandicoots B26 and B37, (ii) 42 SNPs unique to
horse N16, (iii) two SNPs unique to Australian Indigenous SH511
and 1979 isolates, and a third sSNP is shared with horse N16,
koala LPCoLN, bandicoot B26 and bandicoot B37 isolates, and
(iv) a single bp deletion distinguishing frog DE177 from the non-
Indigenous isolates (identical sequence).
Found at: doi:10.1371/journal.ppat.1000903.s014 (5.43 MB PDF)
Figure S15 Multiple sequence alignment of SctC. This
gene segment can differentiate animal isolates from Indigenous
and non-Indigenous human isolates, on the basis of five key SNPs:
Two SNPs (position 232; A/C and 273; A/C) distinguish
bandicoot B26, koala LPCoLN, frog DE177 and Indigenous
human isolates SH511 and 1979 from the non-Indigenous human
isolates AR39, CWL029, J138, TW183, TOR1 and WA97001
(identical sequences); frog DE177 has one unique SNP (position
342; T); koala LPCoLN and bandicoot B26 have one shared SNP
(position 429; G); Australian Indigenous human isolates SH511
1979 have one shared SNP (position 469; A).
Found at: doi:10.1371/journal.ppat.1000903.s015 (1.17 MB PDF)
Figure S16 Multiple sequence alignment of HAF. The
sequenced human C. pneumoniae genomes are truncated (120 bp
deletion), whereas additional human isolates (TOR1, WA97001,
SH511, and 1979) and animal isolates (B26, DE177 and N16) are
not truncated.
Found at: doi:10.1371/journal.ppat.1000903.s016 (2.31 MB PDF)
Figure S17 Multiple sequence alignment of guaB. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s017 (1.26 MB PDF)
Figure S18 Multiple sequence alignment of guaA. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s018 (1.08 MB PDF)
Figure S19 Multiple sequence alignment of add. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s019 (2.87 MB PDF)
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ORF00678. Horse N16 has four indels (positions 73-84, 151-
305, 387-395 and 419-425), relative to frog DE177, bandicoot B26
and koala LPCoLN.
Found at: doi:10.1371/journal.ppat.1000903.s020 (0.77 MB PDF)
Figure S21 Multiple sequence alignment of SSR2. Horse
N16 has a 165 bp indel at positions 66-230 bp.
Found at: doi:10.1371/journal.ppat.1000903.s021 (0.58 MB PDF)
Figure S22 Multiple sequence alignment of helicase.
The nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s022 (0.64 MB PDF)
Figure S23 Multiple sequence alignment of PGP3D. The
nucleotide and amino acid alignments were generated using
Geneious version 4.7, where each nucleotide and amino acid is
assigned its own colour. White shading indicates an amino acid
variant.
Found at: doi:10.1371/journal.ppat.1000903.s023 (0.47 MB PDF)
Table S1 Chlamydia pneumoniae isolates used in this
study. Complete list of C. pneumoniae isolates and description of
their natural host, year of isolation, specimen type and reference.
NA, information not available.
Found at: doi:10.1371/journal.ppat.1000903.s024 (0.05 MB
DOC)
Table S2 Synonymous SNP profile for 10 selected genes
and their genotype designation. Complete list of C.
pneumoniae isolates and corresponding nucleotide base pairs at
particular locations, across eight genes. Genotypes were designated
A-E. Dashes indicate no sequence analysed.
Found at: doi:10.1371/journal.ppat.1000903.s025 (0.03 MB XLS)
Table S3 Oligonucleotide primers used in this study.
The fragment sizes are estimated from koala LPCoLN and human
AR39 sequences. * Designed using Primer3 v.0.4.0.
Found at: doi:10.1371/journal.ppat.1000903.s026 (0.06 MB
DOC)
Text S1 Key genomic data supporting two evolutionary
lineages.
Found at: doi:10.1371/journal.ppat.1000903.s027 (0.03 MB
DOC)
Acknowledgments
We are grateful to Konrad Sachse for providing us with DE177 DNA, Alan
Hudson for providing TOR1 DNA, Ian Clarke for N16 DNA, Andreas
Pospischil for 2040.3 DNA, and Margaret Hammerschlag whom provided
B10, B26 and B37 DNA.
Author Contributions
Conceived and designed the experiments: CMM PT. Performed the
experiments: CMM. Analyzed the data: CMM GSAM PT. Contributed
reagents/materials/analysis tools: SH. Wrote the paper: CMM RB PT.
Carried out the genetic studies (PCR and gene sequencing), data analysis,
manuscript writing: CMM. Revised the article critically for important
intellectual content: SH RB. Managed the genome sequencing: GSAM.
Conceived of the study and participated in its design, and contributed to
the intellectual content of the manuscript: PT. All authors read and
approved the final manuscript.
References
1. Grayston JT (1965) Immunisation against trachoma. Pan Am Health Organ Sci
Publ 147: 549.
2. Storey CC, Lusher M, Yates P, Richmond SJ (1993) Evidence for Chlamydia
pneumoniae of non-human origin. J Gen Microbiol 139: 2621–2626.
3. Bodetti TJ, Jacobson E, Wan C, Hafner L, Pospischil A, et al. (2002) Molecular
evidence to support the expansion of the host range of Chlamydophila pneumoniae to
include reptiles as well as humans, horses, koalas and amphibians. Syst App
Microbiol 25: 146–152.
4. Berger L, Volp K, Mathews S, Speare R, Timms P (1999) Chlamydia pneumoniae in
a free-ranging giant barred frog (Mixophyes iteratus) from Australia. J Clin
Microbiol 37: 2378–2380.
5. Hotzel H, Grossmann E, Mutschmann F, Sachse K (2001) Genetic
characterization of a Chlamydophila pneumoniae isolate from an African frog and
comparison to currently accepted biovars. Syst Appl Microbiol 24: 63–66.
6. Wardrop S, Fowlder A, O’Callaghan P, Giffard P, Timms P (1999)
Characterization of the koala biovar of Chlamydia pneumoniae at four gene loci–
ompAVD4, ompB, 16S rRNA, groESL spacer region. Syst Appl Microbiol 22:
22–27.
7. Kutlin A, Roblin PM, Kumar S, Kohlhoff S, Bodetti T, et al. (2007) Molecular
characterization of Chlamydophila pneumoniae isolates from Western barred
bandicoots. J Med Microbiol 56: 407–417.
8. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae
and atherosclerosis. J Infect Dis 181 (Suppl 3): S402–S410.
9. Kuo CC, Jackson LA, Campbell LA, Grayson JT (1995) Chlamydia pneumoniae
TWAR. Clin Microbiol Rev 8: 451–461.
10. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, et al. (1988)
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic
coronary heart disease and acute myocardial infarction. Lancet 2: 983–986.
11. Wesslen L, Pahlson C, Friman G, Fohlman J, Lindquist O, et al. (1992)
Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected
death in a Swedish elite orienteer. Lancet 340: 427–428.
12. Sriram S, Mitchell W, Stratton C (1998) Multiple sclerosis associated with
Chlamydia pneumoniae infection of the CNS. Neurology 50: 571–572.
13. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, et al. (1998)
Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain.
Med Microbiol Immunol 187: 23–42.
14. Read TD, Brunham RC, Shen C, Gill SR, Heidelberg JF, et al. (2000) Genome
sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic
Acids Res 6: 1397–1406.
15. Kalman S, Mitchell W, Marathe R, Lammel C, Fan J, et al. (1999) Comparative
genomes of Chlamydia pneumoniae and C. trachomatis. Nature Genetics 21: 385–389.
16. Shirai M, Kirakawa H, Kimoto M, Tabuchi M, Kishi F, et al. (2000)
Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan
and CWL029 from USA. Nucleic Acids Res 12: 2311–2314.
17. Geng MM, Schuhmacher A, Muehldorfer I, Bensch KW, Schaefer KP, et al.
(2003) The genome sequence of Chlamydia pneumoniae TW183 and comparison
with other Chlamydia strains based on whole genome sequence analysis. Genbank
Accession No AE009440.
18. Rattei T, Ott S, Gutacker M, Rupp J, Maass M, et al. (2007) Genetic diversity of
the obligate intracellular bacterium Chlamydophila pneumoniae by genome-wide
analysis of single nucleotide polymorphisms: evidence for highly clonal
population structure. BMC Genomics 8: 355.
19. Peeling RW, Brunham RC (1996) Chlamydiae as pathogens: new species and
new issues. Emerg Infect Dis 2: 307–319.
20. Wills JM, Watson G, Lusher M, Mair TS, Wood D, et al. (1990)
Characterisation of Chlamydia psittaci isolated from a horse. Vet Microbiol 24:
11–19.
21. Glassick T, Giffard P, Timms P (1996) Outer membrane protein 2 gene
sequence indicates that Chlamydia pecorum and Chlamydia pneumoniae cause infection
in koalas. Syst Appl Microbiol 19: 457–464.
22. Myers GSA, Mathews SA, Eppinger M, Mitchell C, O’Brien KK, et al. (2009)
Evidence that human Chlamydia pneumoniae was zoonotically acquired. J Bacteriol
191: 7225–7233.
23. Abromaitis S, Hefty PS, Stephens RS (2009) Chlamydia pneumoniae encodes a
functional aromatic amino acid hydroxylase. FEMS Immunol Med Microbiol
55: 196–205.
24. Zhang YX, Fox JG, Ho Y, Zhang L, Stills HF, Jr., et al. (1993) Comparison of
the major outer-membrane protein (MOMP) gene of mouse pneuomonitis
(MoPn) and hamster SFPD strains of Chlamydia trachomatis with other Chlamydia
strains. Mol Biol Evol 10: 1327–1342.
25. Stothard DR, Boguslawski G, Jones RB (1998) Phylogenetic analysis of the
Chlamydia trachomatis major outer membrane protein and examination of
potential pathogenic determinants. Infect Immun 66: 3618–3625.
26. Brunelle BW, Sensabaugh GF (2006) The ompA gene in Chlamydia trachomatis
differs in phylogeny and rate of evolution from other regions of the genome.
Infect Immun 74: 578–585.
27. Everett KD, Bush RM, Andersen AA (1999) Emended description of the order
Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov.,
each containing one monotypic genus, revised taxonomy of the family
Chlamydia pneumoniae Is Genetically Diverse
PLoS Pathogens | www.plospathogens.org 10 May 2010 | Volume 6 | Issue 5 | e1000903Chlamydiaceae, including a new genus and five new species, and standards for the
identification of organisms. Int J Syst Bacteriol 49: 415–440.
28. Reed KD, Ruth GR, Meyer JA, Shukla SK (2000) Chlamydia pneumoniae infection
in a breeding colony of African clawed frogs (Xenopus tropicalis). Emerg Infect Dis
6: 196–199.
29. Pettersson B, Andersson A, Leitner T, Olsvik O, Uhlen M, et al. (1997)
Evolutionary relationships among members of the genus Chlamydia based on 16S
ribosomal DNA analysis. J Bacteriol 179: 4195–4205.
30. Wilson PA, Phipps J, Samuel D, Saunders NA (1996) Development of a
simplified polymerase chain reaction-enzyme immunoassay for the detection of
Chlamydia pneumoniae. J Appl Bacteriol 80: 431–438.
31. Kwon SJ, Lee KJ, Choen DS, Kim KS, Lee SJ (2004) The sequence of 16S
rRNA of Korean isolate Chlamydia pneumoniae LKK-1. Unpublished 2004,
Submitted (February-2004) to the EMBL/GenBank/DDBJ databases.
32. Hatch TP, Allan I, Pearce JH (1984) Structural and polypeptide differences
between envelopes of infective and reproductive life cycle forms of Chlamydia spp.
J Bacteriol 157: 13–20.
33. Thomas NS, Lusher M, Storey CC, Clarke IN (1997) Plasmid diversity in
Chlamydia. Microbiol 143: 1847–1854.
34. Gray A (1988) Society and culture: demographic and social history. In: Jupp J,
ed. The Australian people: An encyclopedia of the nation, its people and their
origins. Oakleigh: Cambridge University press. 88 p.
35. Moor PE, Collignon PC, Gilbert GL (1999) Pulsed-field gel electrophoresis used
to investigate genetic diversity of Haemophilus influenzae type b isolates in Australia
shows differences between Aboriginal and non-Aboriginal isolates. J Clin
Microbiol 37: 1524–1531.
36. Cochrane M, Walker P, Gibbs, Timms P (2005) Multiple genotypes of Chlamydia
pneumoniae identified in human carotid plaque. Microbiol 151: 2285–2290.
37. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for
biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics Methods
and Protocols: Methods in Molecular Biology. TotowaNJ: Humana Press. pp
365–386.
38. Drummond AJ, Ashton B, Cheung M, Heled J, Kearse M, et al. (2007) Geneious
version 4.7. Available: http://www.geneious.com/. Accessed 13 August 2009.
39. Dwyer RS, Treharne JD, Jones BR, Herring J (1972) Chlamydial infection.
Results of micro-immunofluorescence tests for the detection of type-specific
antibody in certain chlamydial infections. Br J Vener Dis 48: 452–459.
40. Coles KA, Timms P, Smith DW (2001) Koala biovar of Chlamydia pneumoniae
infects human and koala monocytes and induces increased uptake of lipids in
vitro. Infect Immun 69: 7894–7897.
41. Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gerard HC, Whittum-Hudson J,
et al. (2008) Initial characterization of Chlamydophila (Chlamydia) pneumoniae
cultured from the late-onset Alzheimer brain. Int J Med Microbiol 299:
187–201.
42. Ramirez JA (1996) Isolation of Chlamydia pneumoniae from the coronary artery of a
patient with coronary atherosclerosis. Ann Intern Med 125: 979–982.
43. Lee SJ, Nam EC, Won J, Park WS, Kim WJ, et al. (2003) Characterization of
the first Korean isolate of a Chlamydia pneumoniae strain. J Infect Dis Japan 56:
62–64.
44. Hutton S, Dodd H (1993) C. pneumoniae successfully isolated. Current topics. pp
42–43.
45. Asche VL, Hutton SI, Douglas FP (1993) Serological evidence of the three
chlamydial species in an Aboriginal community in the Northern Territory.
Med J Aust 158: 606–604.
46. Warren K, Swan R, Bodetti T, Friend T, Hill S, et al. (2005) Ocular Chlamydiales
infections of Western barred bandicoots (Perameles bougainville) in Western
Australia. J Zoo Wildl Med 36: 100–102.
47. Blumer C, Zimmermann DR, Weilenmann R, Vaughan L, Pospischil A (2007)
Chlamydiae in free-ranging and captive frogs in Switzerland. Vet Pathol 44:
144–150.
Chlamydia pneumoniae Is Genetically Diverse
PLoS Pathogens | www.plospathogens.org 11 May 2010 | Volume 6 | Issue 5 | e1000903